Martin Tami Tillotson

Average Profitability
29.48%
Insider Buys Quantity
1
Insider Buys Sum
$12,500.00
Insider Sells Quantity
7
Insider Sells Sum
$1.26M

Insider Activity of Martin Tami Tillotson

According to the SEC Form 4 filings, Martin Tami Tillotson, being in a position of

  1. Sr. V.P., Regulatory Affairs at Supernus Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 8000 shares for $223,280,
    over all time since 2012-05-04, has bought 2500 shares for $12,500, and sold 43735 shares for $1.26M.

The largest purchase of all time was on 2012-05-04 and amounted to 2500 shares of Supernus Pharmaceuticals, Inc. for $12,500.

The largest sale of all time was on 2023-08-30 and amounted to 8100 shares of Supernus Pharmaceuticals, Inc. for $259,200.

Biography of Martin Tami Tillotson

No biography is available at this moment.

2024-01-10SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
8,000
0.0146%
$27.91$223,280+11.48%
2023-08-30SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
8,100
0.0149%
$32.00$259,200-11.39%
2023-08-25SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
5,135
0.0095%
$31.59$162,215-9.81%
2022-08-22SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
5,000
0.0095%
$35.98$179,900-0.88%
2022-08-04SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
5,000
0.0093%
$32.98$164,900+6.72%
2021-04-14SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
6,250
0.0083%
$22.48$140,500-5.62%
2021-04-13SaleSupernus Pharmaceuticals, Inc.
SUPN
Sr. V.P., Regulatory Affairs
6,250
0.0081%
$21.48$134,264-3.87%
2012-05-04PurchaseSupernus Pharmaceuticals, Inc.
SUPN
VP of Regulatory Affairs
2,500
0.0124%
$5.00$12,500+29.48%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.